5-HTP

5-HTP is an aromatic amino acid derivative that sits one step downstream of tryptophan and one step upstream of serotonin in the serotonergic pathway ^[1][2]. Because tryptophan hydroxylase, the enzyme that makes 5-HTP from tryptophan, is the rate-limiting step in serotonin production, supplying 5-HTP directly bypasses that bottleneck and enlarges the pool of substrate available for serotonin synthesis ^[1][2]. Commercially, the 5-HTP used in supplements is typically extracted from the seeds of the West African plant Griffonia simplicifolia.

Research on 5-HTP has centered most heavily on mood. Reviews of double-blind, placebo-controlled trials have examined its use in depression, while smaller literatures describe reported effects in fibromyalgia, chronic headache, appetite and binge eating, and insomnia ^[1][2]. Its role as a serotonin precursor has also been explored in less obvious settings; in a mouse model of sudden unexpected death in epilepsy, 5-HTP reduced seizure-induced respiratory arrest, consistent with a contribution of serotonergic signaling to that event ^[3]. Because much of an oral dose is decarboxylated to serotonin outside the brain, some clinical work has paired it with peripheral decarboxylase inhibitors such as carbidopa to increase the amount reaching the central nervous system ^[1].

In the United States 5-HTP is marketed as a dietary supplement rather than an approved drug, and as of the mid-2020s no FDA-approved medicine contains it; in some other countries the same molecule has been used pharmaceutically under the name oxitriptan. It is usually sold as capsules, tablets, or powder. Safety discussion centers on two issues: the potential for serotonin syndrome when it is combined with other serotonin-raising drugs, and eosinophilia-myalgia syndrome, a serious condition historically associated with contaminated products in this amino acid class, which has kept long-term safety a subject of caution ^[1].

Most people tolerate low doses, but nausea, cramping, and loose stools are the usual complaints because of peripheral serotonin in the gut. The real concern is combining it with SSRIs, SNRIs, MAOIs, triptans, or other serotonergic agents, which raises serotonin syndrome risk; don't do that without medical supervision. Taking it with a peripheral decarboxylase inhibitor (like carbidopa) is how it's sometimes used clinically to cut side effects, but that's prescription territory. Long-term safety data are thin, so it suits short-term use rather than indefinite supplementation.

5-Hydroxytryptophan (5-HTP), the immediate biochemical precursor of serotonin, was characterized in the mid-twentieth century as researchers mapped the tryptophan-to-serotonin pathway, in which the enzyme tryptophan hydroxylase converts L-tryptophan to 5-HTP and aromatic L-amino acid decarboxylase then yields serotonin. Because it crosses the blood-brain barrier and bypasses the rate-limiting hydroxylation step, 5-HTP was investigated from the 1970s onward as a serotonergic agent for depression, and it was formulated pharmaceutically under the name oxitriptan in several European countries. Commercial 5-HTP is not synthesized but extracted from the seeds of the West African plant Griffonia simplicifolia, a source that made it practical to sell as a dietary supplement in the United States and elsewhere once demand for over-the-counter mood and sleep products grew.

5-HTP is one of the more widely used serotonergic supplements, valued by consumers for its plausible mechanism and its reputation for supporting mood, sleep onset, and appetite regulation. Controlled evidence exists but is generally modest in size and quality, and enthusiasm often outpaces the data; reviewers note that while some trials suggest antidepressant activity, the studies are frequently small and short. It is also viewed with a degree of caution: its short half-life encourages divided or timed-release dosing, combining it with serotonergic drugs raises the theoretical risk of serotonin syndrome, and older concerns about a contaminant known as peak X, linked historically to eosinophilia-myalgia syndrome in tryptophan products, keep sourcing and purity a recurring topic among careful users.